Playlist

Awaza Hosts Curtain Raiser Event for the 12th International Day of Yoga

08 Jun. 12:22

Source

AWAZA, June 7, 2026 — The beautiful resort city of Awaza played host to a vibrant Curtain Raiser event today, marking the upcoming celebrations of the 12th International Day of Yoga. The gathering brought together numerous participants to promote global health, harmony, and peace. Established by the United Nations General Assembly in 2014 and celebrated annually on June 21, the official theme for this year's International Yoga Day is "Yoga for Healthy Ageing," highlighting the practice's profound benefits for wellness and wisdom.

Originating in India over 5,000 years ago, yoga has evolved into a vital contemporary tool for stress reduction and overall well-being. Since 2015, it has served as a crucial cultural and spiritual bridge in India-Turkmenistan relations. A prime example of this enduring bond is the Yoga and Traditional Medicine Centre at the Bagtyyarlyk Sports Complex in Ashgabat, which was inaugurated during Indian Prime Minister Narendra Modi’s visit to Turkmenistan. The Indian Embassy expressed its deep gratitude to the Government of Turkmenistan for its continuous support in running the centre and co-hosting annual mass yoga sessions.

The event concluded with an inspiring call to incorporate yoga into daily routines, emphasizing that it is a free, accessible practice for all ages that enhances memory, builds inner strength, and promotes focus. Participants united in a shared commitment to health and harmony, exchanging warm wishes for a Happy International Day of Yoga 2026.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌